OTCPK:CRRV.F

Stock Analysis Report

Executive Summary

CVR Medical Corp., a healthcare company, engages in the development and advancement of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • CVR Medical has significant price volatility in the past 3 months.
  • CVR Medical is not covered by any analysts.

Share Price & News

How has CVR Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-30.7%

CRRV.F

1.1%

US Medical Equipment

-0.6%

US Market


1 Year Return

-79.1%

CRRV.F

9.9%

US Medical Equipment

0.7%

US Market

CRRV.F underperformed the Medical Equipment industry which returned 9.9% over the past year.

CRRV.F underperformed the Market in United States of America which returned 0.6% over the past year.


Share holder returns

CRRV.FIndustryMarket
7 Day-30.7%1.1%-0.6%
30 Day-55.0%1.3%2.9%
90 Day-81.8%3.0%1.3%
1 Year-79.1%-79.1%10.8%9.9%2.9%0.7%
3 Yearn/a70.1%64.9%44.6%35.2%
5 Yearn/a138.9%111.8%61.9%44.2%

Price Volatility Vs. Market

How volatile is CVR Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is CVR Medical undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether CVR Medical is trading at an attractive price based on the cash flow it is expected to produce in the future. But as CVR Medical has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of CRRV.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through CVR Medical regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is CVR Medical expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CVR Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of CRRV.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access CVR Medical's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has CVR Medical performed over the past 5 years?

-58.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

CVR Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare CVR Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare CVR Medical's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if CVR Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if CVR Medical has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if CVR Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is CVR Medical's financial position?


Financial Position Analysis

CVR Medical's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

CVR Medical has no long term commitments.


Debt to Equity History and Analysis

CVR Medical has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if CVR Medical's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

CVR Medical has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

CVR Medical has less than a year of cash runway based on current free cash flow.

CVR Medical has less than a year of cash runway if free cash flow continues to grow at historical rates of 49.2% each year.


Next Steps

Dividend

What is CVR Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate CVR Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate CVR Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as CVR Medical has not reported any payouts.

Unable to verify if CVR Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as CVR Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of CVR Medical's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

Peter Bakema 0

3yrs

Tenure

US$143,336

Compensation

Mr. Peter Bakema has been the Chief Executive Officer and President of Big Bar Resources Corp. (Also known as CVR Medical Corp.) since September 27, 2016 and has been its Chairman since August 2018. Mr. Ba ...


CEO Compensation Analysis

Peter's remuneration is lower than average for companies of similar size in United States of America.

Insufficient data for Peter to compare compensation growth.


Management Age and Tenure

2.0yrs

Average Tenure

The tenure for the CVR Medical management team is about average.


Board Age and Tenure

1.3yrs

Average Tenure

The average tenure for the CVR Medical board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Erwin Wong (51yo)

    Strategic Financial Consultant

    • Tenure: 1.3yrs
    • Compensation: US$85.15k
  • Jeremy Poirier (33yo)

    Consultant

    • Tenure: 2yrs
  • Dallas Hack

    Interim CFO & Director

    • Tenure: 1.3yrs
  • Peter Bakema

    President

    • Tenure: 3yrs
    • Compensation: US$143.34k
  • Paul Blunden

    Medical Advisor & Director

    • Tenure: 3yrs
  • Tony Robinson

    COO & Executive VP

    • Tenure: 3yrs
  • Orville Day

    Lead Physicist

    • Tenure: 0yrs
  • Alan Langston

    Vice President of Sales & Marketing

    • Tenure: 2yrs

Board Members

  • Dallas Hack

    Interim CFO & Director

    • Tenure: 1.3yrs
  • Peter Bakema

    President

    • Tenure: 3yrs
    • Compensation: US$143.34k
  • Paul Blunden

    Medical Advisor & Director

    • Tenure: 3yrs

Company Information

CVR Medical Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CVR Medical Corp.
  • Ticker: CRRV.F
  • Exchange: OTCPK
  • Founded: 1980
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$25.276m
  • Listing Market Cap: CA$19.059m
  • Shares outstanding: 126.38m
  • Website: https://cvrmed.com

Location

  • CVR Medical Corp.
  • 4664 Sierra View Drive
  • Denver
  • North Carolina
  • 28037
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
B3BNDB (Deutsche Boerse AG)YesCommon SharesDEEURSep 1988
CVMTSXV (TSX Venture Exchange)YesCommon SharesCACADSep 1988
CRRV.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDSep 1988
B3BNMUN (Boerse Muenchen)YesCommon SharesDEEURSep 1988

Biography

CVR Medical Corp., a healthcare company, engages in the development and advancement of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/22 00:11
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.